These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 25136879

  • 1. Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention.
    Angeli F, Verdecchia P, Savonitto S, Arraiz G, Zaninotto M, Broccatelli A, Cosma C, De Servi S, Sabino F, Briguori C, Ambrosio G, Cavallini C, Italian “Atherosclerosis, Thrombosis and Vascular Biology” and “Society for Invasive Cardiology-GISE” Investigators.
    EuroIntervention; 2015 Nov; 11(7):757-64. PubMed ID: 25136879
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
    Kilic T, Oner G, Ural E, Yumuk Z, Sahin T, Bildirici U, Acar E, Celikyurt U, Kozdag G, Ural D.
    Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
    [Abstract] [Full Text] [Related]

  • 3. Long-term prognosis of complete percutaneous coronary revascularisation in patients with diabetes with multivessel disease.
    Jiménez-Navarro MF, López-Jiménez F, Barsness G, Lennon RJ, Sandhu GS, Prasad A.
    Heart; 2015 Aug; 101(15):1233-9. PubMed ID: 25882502
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
    Otaki Y, Takahashi H, Watanabe T, Yamaura G, Funayama A, Arimoto T, Shishido T, Miyamoto T, Kubota I.
    Circ J; 2015 Aug; 79(11):2480-6. PubMed ID: 26354502
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
    Rebholz CM, Grams ME, Matsushita K, Inker LA, Foster MC, Levey AS, Selvin E, Coresh J.
    Clin J Am Soc Nephrol; 2015 Jun 05; 10(6):941-8. PubMed ID: 25825481
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Cockcroft-Gault and modification of diet in renal disease formulas as predictors of cardiovascular outcomes in patients with myocardial infarction treated with primary percutaneous coronary intervention.
    Ekmekci A, Uluganyan M, Gungor B, Tufan F, Cekirdekci EI, Ozcan KS, Erer HB, Orhan A, Osmanov D, Bozbay M, Cicek G, Sayar N, Eren M.
    Angiology; 2014 Oct 05; 65(9):838-43. PubMed ID: 24101712
    [Abstract] [Full Text] [Related]

  • 10. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H, Ishii J, Kawai T, Hattori K, Ishikawa M, Okumura M, Kan S, Nakano T, Matsui S, Nomura M, Hishida H, Ozaki Y.
    Am J Med; 2009 Jun 05; 122(6):566-73. PubMed ID: 19393984
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Kidney function estimating equations in patients with chronic kidney disease.
    Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L.
    Int J Clin Pract; 2011 Apr 05; 65(4):458-64. PubMed ID: 21401834
    [Abstract] [Full Text] [Related]

  • 13. Estimating glomerular filtration rate in acute coronary syndromes: Different equations, different mortality risk prediction.
    Almeida I, Caetano F, Barra S, Madeira M, Mota P, Leitão-Marques A.
    Eur Heart J Acute Cardiovasc Care; 2016 Jun 05; 5(3):223-30. PubMed ID: 25740222
    [Abstract] [Full Text] [Related]

  • 14. Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure.
    Damman K, van der Harst P, Smilde TD, Voors AA, Navis G, van Veldhuisen DJ, Hillege HL.
    Heart; 2012 Feb 05; 98(4):319-24. PubMed ID: 22038544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Woitas RP, Kleber ME, Meinitzer A, Grammer TB, Silbernagel G, Pilz S, Tomaschitz A, Weihrauch G, Dobnig H, März W, Scharnagl H.
    Atherosclerosis; 2013 Aug 05; 229(2):541-8. PubMed ID: 23706287
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
    Li HX, Xu GB, Wang XJ, Zhang XC, Yang JM.
    Chin Med J (Engl); 2010 Mar 20; 123(6):745-51. PubMed ID: 20368098
    [Abstract] [Full Text] [Related]

  • 20. Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting.
    Dardashti A, Nozohoor S, Grubb A, Bjursten H.
    Scand J Clin Lab Invest; 2016 Mar 20; 76(1):74-81. PubMed ID: 26647957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.